For: | Yue H, Na YL, Feng XL, Ma SR, Song FL, Yang B. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer. World J Gastroenterol 2003; 9(2): 377-380 [PMID: 12532471 DOI: 10.3748/wjg.v9.i2.377] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i2/377.htm |
Number | Citing Articles |
1 |
Ke-Jun Nan, Hui Guo, Zhi-Ping Ruan, Zhao Jing, Shaan-Xi Liu. Expression of p57<sup>kip2</sup> and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma. World Journal of Gastroenterology 2005; 11(8): 1237-1240 doi: 10.3748/wjg.v11.i8.1237
|
2 |
Haiyan Wei, Chunyou Wang, Libo Chen. Proliferating Cell Nuclear Antigen, Survivin, and CD34 Expressions in Pancreatic Cancer and Their Correlation With Hypoxia-Inducible Factor 1α. Pancreas 2006; 32(2): 159 doi: 10.1097/01.mpa.0000202961.71600.9b
|
3 |
Kun Wu, Lan Zhao, Yao Li, Yu-Juan Shan, Li-Jie Wu. Effects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical significance. World Journal of Gastroenterology 2004; 10(7): 945-949 doi: 10.3748/wjg.v10.i7.945
Abstract(1080) |
Core Tip(941) |
Full Article(HTML)(1723)
|
Full Article (PDF)-338K(351)
|
Times Cited (0)
|
Total Visits (4715)
|
Open
|
4 |
Jun Chen, Shu-Lan Huang, Tao Li, Xi-Lan Chen. In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry. Neuroradiology 2006; 48(5): 312 doi: 10.1007/s00234-006-0066-3
|
5 |
Ren Jie Jin, Yongsoo Lho, Yongqing Wang, Mingfang Ao, Monica Patricia Revelo, Simon W. Hayward, Marcia L. Wills, Susan K. Logan, Pumin Zhang, Robert J. Matusik. Down-regulation of p57Kip2 Induces Prostate Cancer in the Mouse. Cancer Research 2008; 68(10): 3601 doi: 10.1158/0008-5472.CAN-08-0073
|
6 |
Xin Shi, JÖrg Kleeff, Zhao-Wen Zhu, Bruno Schmied, Wen-Hao Tang, Arthur Zimmermann, Markus W. BÜchler, Helmut Friess. Gene-expression analysis of single cells-nested polymerase chain reaction after laser microdissection. World Journal of Gastroenterology 2003; 9(6): 1337-1341 doi: 10.3748/wjg.v9.i6.1337
|
7 |
Eid Alshammari, Ying-Xue Zhang, Zhe Yang. Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer. World Journal of Gastroenterology 2022; 28(29): 3753-3766 doi: 10.3748/wjg.v28.i29.3753
|
8 |
Ioannis S. Pateras, Kalliopi Apostolopoulou, Katerina Niforou, Athanassios Kotsinas, Vassilis G. Gorgoulis. p57KIP2: “Kip”ing the Cell under Control. Molecular Cancer Research 2009; 7(12): 1902 doi: 10.1158/1541-7786.MCR-09-0317
|
9 |
Hetal A. Sarvaiya, Jung H. Yoon, Iulia M. Lazar. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation. Rapid Communications in Mass Spectrometry 2006; 20(20): 3039 doi: 10.1002/rcm.2677
|
10 |
Jun-Ming Guo, Bing-Xiu Xiao, De-Jian Dai, Qiong Liu, Hong-Hui Ma. Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells <i>in vitro</i>. World Journal of Gastroenterology 2004; 10(6): 860-863 doi: 10.3748/wjg.v10.i6.860
|
11 |
Jianyang Wang, Hong Zhao, Jing Yu, Xin Xu, Wenyang Liu, Hao Jing, Ning Li, Yuan Tang, Yexiong Li, Jianqiang Cai, Jing Jin. MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR) -based radiotherapy. Biomedicine & Pharmacotherapy 2019; 110: 646 doi: 10.1016/j.biopha.2018.11.080
|
12 |
P Vlachos, U Nyman, N Hajji, B Joseph. The cell cycle inhibitor p57Kip2 promotes cell death via the mitochondrial apoptotic pathway. Cell Death & Differentiation 2007; 14(8): 1497 doi: 10.1038/sj.cdd.4402158
|
13 |
Shu-Qiang Yue, Yan-Ling Yang, Ke-Feng Dou, Kai-Zong Li. Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis. World Journal of Gastroenterology 2003; 9(12): 2863-2865 doi: 10.3748/wjg.v9.i12.2863
|
14 |
Tomasz Urbanek, Barbara Skop, Krzysztof Ziaja, Tadeusz Wilczok, Ryszard Wiaderkiewicz, Artur Pal/asz, Urszula Mazurek, Ewa Wielgus. Sapheno-Femoral Junction Pathology: Molecular Mechanism of Saphenous Vein Incompetence. Clinical and Applied Thrombosis/Hemostasis 2004; 10(4): 311 doi: 10.1177/107602960401000403
|